Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction
Abstract As the most malignant tumor, the prognosis of pancreatic cancer is not ideal even in the small number of patients who can undergo radical surgery. As a highly heterogeneous tumor, chemotherapy resistance is a major factor leading to decreased efficacy and postoperative recurrence of pancrea...
Main Authors: | Tianhong Teng, Han Shi, Yanying Fan, Pengfei Guo, Jin Zhang, Xinyu Qiu, Jianghua Feng, Heguang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-56737-4 |
Similar Items
-
Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer
by: Ding H, et al.
Published: (2023-03-01) -
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
by: Hayato Muranaka, et al.
Published: (2023-06-01) -
Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
by: Lukas M. Braun, et al.
Published: (2020-05-01) -
Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy
by: Maozhen Peng, et al.
Published: (2023-04-01) -
Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
by: Fleur van der Sijde, et al.
Published: (2019-01-01)